Key Insights

Highlights

Success Rate

100% trial completion (above average)

Clinical Risk Assessment

Based on trial outcomes

Moderate Risk

Score: 40/100

Termination Rate

0.0%

0 terminated out of 5 trials

Success Rate

100.0%

+13.5% vs benchmark

Late-Stage Pipeline

20%

1 trials in Phase 3/4

Results Transparency

0%

0 of 2 completed with results

Key Signals

100% success

Data Visualizations

Phase Distribution

5Total
Not Applicable (1)
P 1 (3)
P 3 (1)

Trial Status

Completed2
Recruiting2
Active Not Recruiting1

Trial Success Rate

100.0%

Benchmark: 86.5%

Based on 2 completed trials

Clinical Trials (5)

Showing 5 of 5 trials
NCT07115043Phase 1Recruiting

A Study to Investigate Safety of AZD6750 in Adult Participants With Select Advanced or Metastatic Solid Tumors

NCT06384053Not ApplicableRecruiting

Skin Cancer and Hyperthermia and Radiotherapy

NCT05620134Phase 1Active Not Recruiting

Study of JK08 in Patients with Unresectable Locally Advanced or Metastatic Cancer

NCT02997553Phase 3Completed

Fluorescence for Sentinel Lymph Node Identification in Cancer Surgery

NCT01017185Phase 1Completed

Study of HF10 in Patients With Refractory Head and Neck Cancer or Solid Tumors With Cutaneous and/or Superficial Lesions

Showing all 5 trials

Research Network

Activity Timeline